Positive Effects of a Lecithin-Based Delivery Form of Boswellia serrata Extract in Acute Diarrhea of Adult Subjects

Acute diarrhea is a frequent problem worldwide, mostly due to gastrointestinal infections or food poisoning. Boswellia serrata could be active in the treatment of acute diarrhea due to its anti-inflammatory, antispasmodic, and antimicrobial activity. In this randomized, double-blind, placebo-controlled clinical study, 49 adults with acute diarrhea were randomly allocated to receive 250 mg of a lecithin-based delivery form of Boswellia serrata (CASP) or placebo for 5 days. The time it took to become healthy with stoppage of diarrhea (primary end point) was significantly shorter in the intervention group (3.08 vs. 4.44 days: p-value < 0.0001). The probability of subjects treated with CASP to recover sooner was equal to 80.2%. A significantly lower number of stools was observed in the CASP group over time (β = −0.17, p-value < 0.0001). A significant difference was observed between the two groups for abdominal pain, nausea, and GAE (global assessment of efficacy). In conclusion, the lecithin-based delivery form of Boswellia serrata extract could be a useful addition to the treatment of acute diarrhea in adults. CASP is safe and reduces the time it takes to become healthy, the frequency of stools, the abdominal pain and nausea of subjects with acute diarrhea. Further studies are needed to confirm these promising results.

[1]  A. Matheson,et al.  Racecadotril , 2022, Reactions Weekly.

[2]  M. Underwood,et al.  Probiotic mechanisms of action. , 2019, Early human development.

[3]  G. Belcaro,et al.  Oral administration of a lecithin-based delivery form of boswellic acids (Casperome®) for the prevention of symptoms of irritable bowel syndrome: a randomized clinical study. , 2019, Minerva gastroenterologica e dietologica.

[4]  J. M. Rhoads,et al.  Probiotics in Disease Prevention and Treatment , 2018, Journal of clinical pharmacology.

[5]  T. Wilkins,et al.  Probiotics for Gastrointestinal Conditions: A Summary of the Evidence. , 2017, American family physician.

[6]  G. Belcaro,et al.  Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome. , 2017, European review for medical and pharmacological sciences.

[7]  S. Najafi,et al.  Traditionally used herbal medicines with antibacterial effect on Aggegatibacter actinomycetemcomitans: Boswellia serrata and Nigella sativa , 2016, Journal of Indian Society of Periodontology.

[8]  O. Taha,et al.  Effect of adding intrathecal morphine to a multimodal analgesic regimen for postoperative pain management after laparoscopic bariatric surgery: a prospective, double-blind, randomized controlled trial , 2016, British journal of pain.

[9]  G. Belcaro,et al.  Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract. , 2016, European review for medical and pharmacological sciences.

[10]  Heather Rubino,et al.  Pneumonia Associated with an Influenza A H3 Outbreak at a Skilled Nursing Facility--Florida, 2014. , 2015, MMWR. Morbidity and mortality weekly report.

[11]  M. Carrara,et al.  Boswellia serrata Preserves Intestinal Epithelial Barrier from Oxidative and Inflammatory Damage , 2015, PloS one.

[12]  R. Mueller,et al.  Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon – a placebo‐controlled study , 2013, Alimentary pharmacology & therapeutics.

[13]  O. Werz,et al.  Boswellia serrata , 2011, Clinical pharmacokinetics.

[14]  M. Z. Siddiqui.  Boswellia Serrata, A Potential Antiinflammatory Agent: An Overview , 2011, Indian journal of pharmaceutical sciences.

[15]  D. S. Arora,et al.  Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-β-boswellic acid from Boswellia serrata , 2011, BMC Microbiology.

[16]  R. Tauxe,et al.  Foodborne Illness Acquired in the United States—Unspecified Agents , 2011, Emerging infectious diseases.

[17]  M. Widdowson,et al.  Foodborne Illness Acquired in the United States—Major Pathogens , 2011, Emerging infectious diseases.

[18]  S. Allen,et al.  Probiotics for treating acute infectious diarrhoea , 2010, The Cochrane database of systematic reviews.

[19]  H. Ammon.  Modulation of the immune system by Boswellia serrata extracts and boswellic acids. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[20]  Roger H Jones,et al.  Acute diarrhoea in adults , 2009, BMJ : British Medical Journal.

[21]  D. Tribble,et al.  Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  F. Guarner,et al.  World Gastroenterology Organisation practice guideline: Probiotics and prebiotics. , 2008, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

[23]  O. Werz,et al.  Boswellic acids: biological actions and molecular targets. , 2006, Current medicinal chemistry.

[24]  N. Senninger,et al.  Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[25]  R. Capasso,et al.  Effect of Boswellia serrata on intestinal motility in rodents: inhibition of diarrhoea without constipation , 2006, British journal of pharmacology.

[26]  P. Speelman,et al.  Guideline for the management of acute diarrhea in adults , 2002, Journal of gastroenterology and hepatology.

[27]  J. Aponte,et al.  Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. , 2001, JAMA.

[28]  R. Auckenthaler,et al.  Etiological agents of infectious diarrhea: implications for requests for microbial culture , 1997, Journal of clinical microbiology.

[29]  H. Dupont.  Diarrheal diseases in the developing world. , 1995, Infectious disease clinics of North America.

[30]  M. Osterholm,et al.  Changing epidemiology of food-borne disease: a Minnesota perspective. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  H. Ammon,et al.  Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. , 1991, Planta medica.

[32]  David N. Taylor,et al.  Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial. , 1991, Annals of internal medicine.

[33]  A. Brodribb.  TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE WITH A HIGH-FIBRE DIET , 1977, The Lancet.

[34]  R. Likert.  “Technique for the Measurement of Attitudes, A” , 2022, The SAGE Encyclopedia of Research Design.

[35]  M. A. Amalaradjou,et al.  Antivirulence Properties of Probiotics in Combating Microbial Pathogenesis. , 2017, Advances in applied microbiology.

[36]  J. Crump,et al.  2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  A. Rani,et al.  Determination of Antioxidant Potential in Spilanthes acmella using DPPH assay , 2014 .

[38]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[39]  W. Doe,et al.  Acute diarrhoea in adults. , 1981, Australian family physician.

[40]  J. Bauzá.  [Acute diarrhea]. , 1966, Revista chilena de pediatria.